AVRAHAM PHARMACEUTICALS
Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.
AVRAHAM PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Yavneh, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.avphar.com
Total Employee:
11+
Status:
Active
Contact:
(972) 893-2400
Email Addresses:
[email protected]
Total Funding:
22.2 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Unified Layer Fast Secure Contact Form
Similar Organizations
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Integra LifeSciences
Integra LifeSciences investment in Venture Round - Avraham Pharmaceuticals
Technion Research & Development Foundation
Technion Research & Development Foundation investment in Private Equity Round - Avraham Pharmaceuticals
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Private Equity Round - Avraham Pharmaceuticals
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Venture Round - Avraham Pharmaceuticals
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Series A - Avraham Pharmaceuticals
Pontifax
Pontifax investment in Series A - Avraham Pharmaceuticals
Official Site Inspections
http://www.avphar.com
- Host name: 172.67.214.212
- IP address: 172.67.214.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
